Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...
Nov. 30, 2004 — The U.S. Food and Drug Administration (FDA) and King Pharmaceuticals, Inc., have notified healthcare professionals via letter of labeling changes for existing prescribing and route of ...
Drugmaker Pfizer is warning doctors that it expects to run low on supplies of Bicillin L-A, a long-acting injection of the antibiotic penicillin, the preferred option for treating syphilis during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback